Telix (ASX:TLX) share price jumps 7% on major Merck collaboration

Telix shares are nearing a record high on Wednesday…

| More on:
active person star jumping amid city landscape

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a very strong performer on Wednesday.

The molecularly targeted radiation (MTR) focused biopharmaceutical company's shares have jumped 7% to $6.53 today.

This means the Telix share price is now trading close to its record high of $6.65.

Why is the Telix share price storming higher?

The Telix share price is being bid higher by investors today following the release of a promising announcement this morning.

According to the release, the company has entered into a pan-cancer clinical collaboration with pharmaceutical giant Merck. This builds on the success of a strategic research collaboration agreement between the two companies in 2019.

The release explains that the agreement will see the two parties conduct combination studies with one of Merck's investigational proprietary DNA Damage Response Inhibitor (DDRi) molecules in combination with each of Telix's TLX591 and TLX250 MTR therapeutic programs.

TLX591 and TLX250 are late-stage products in development for prostate and renal cancer therapy, respectively. The collaboration will investigate the synergy of these investigational assets with Merck's DDRi compound across a wide variety of oncology indications.

"The vanguard of nuclear medicine and oncology"

Telix's CEO, Dr. Christian Behrenbruch, appeared to be very pleased with the agreement.

He said: "This collaboration represents the vanguard of nuclear medicine and oncology, and we are excited by the level of new data and intellectual property already generated, which is highly supportive of clinical translation."

"Pre-clinical studies provide evidence that the combined effect of Merck's DDRi compound with Telix's MTR candidates has potential to significantly impact cancer by improving efficacy and reducing the required radiation dose for tumour reduction and remission, compared to MTR only," Dr Behrenbruch added.

Today's gain means the Telix share price is smashing the market in 2021 and now up over 60% year to date.

Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 made it three-for-three losses in a row this Wednesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Brickworks, James Hardie, Megaport, and OFX shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured another day of selling this Tuesday.

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Guess which ASX 300 tech stock is already up 64% in November!

The ASX 300 tech stock is surging higher this month. But why?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ANZ, Block, Neuren, and Pilbara Minerals shares are pushing higher today

These shares are having a solid session on Tuesday. But why? Let's find out.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

4 ASX All Ords shares rocketing over 10% today

These shares started the week with a bang. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Mergers & Acquisitions

Guess which ASX stock just rocketed 40% on takeover news

A colossal company finds value in the small end of our ASX town.

Read more »

Happy diverse colleagues or team of people give high five together to celebrate great teamwork and results.
Share Gainers

Why Black Cat, Dicker Data, Novonix, and Pointsbet shares are racing higher

These shares are starting the week with a bang. But why?

Read more »